3407:TSEAsahi Kasei Corporation Analysis
Data as of 2026-07-23 - not real-time
¥1,866.50
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Asahi Kasei is trading firmly above its short‑term and intermediate moving averages, reinforcing a bullish bias, while the RSI remains in a neutral‑to‑slightly‑positive zone.
However, the MACD histogram has turned negative, hinting at short‑term bearish pressure that could temper upside in the near term. The company’s valuation appears attractive, with a price‑to‑earnings multiple well below the sector average and a price‑to‑sales ratio under one, suggesting the stock is undervalued relative to peers. Dividend yield is solid and the payout ratio sits comfortably within sustainable limits, supported by strong operating cash flow. Low beta and a stable volume profile point to modest volatility and good liquidity, while the target price median from analysts indicates modest upside potential. Overall, the blend of a defensive dividend, attractive valuation, and diversified business exposure makes the stock appealing for investors with a medium‑to‑long horizon.
However, the MACD histogram has turned negative, hinting at short‑term bearish pressure that could temper upside in the near term. The company’s valuation appears attractive, with a price‑to‑earnings multiple well below the sector average and a price‑to‑sales ratio under one, suggesting the stock is undervalued relative to peers. Dividend yield is solid and the payout ratio sits comfortably within sustainable limits, supported by strong operating cash flow. Low beta and a stable volume profile point to modest volatility and good liquidity, while the target price median from analysts indicates modest upside potential. Overall, the blend of a defensive dividend, attractive valuation, and diversified business exposure makes the stock appealing for investors with a medium‑to‑long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above key moving averages supports bullish bias
- negative MACD histogram adds short‑term downside risk
- attractive dividend yield provides cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- valuation metrics indicate significant upside relative to peers
- steady revenue growth and solid cash generation
- sustainable dividend with comfortable payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- diversified conglomerate structure reduces concentration risk
- low volatility and strong balance sheet support resilience
- long‑term growth opportunities in materials, healthcare and renewable energy
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin5.17%
P/E Ratio16.0
ROE8.02%
ROA3.55%
Debt/Equity46.69
P/B Ratio1.2
Op. Cash Flow¥303.1B
Free Cash Flow¥17.2B
Industry P/E31.2
Technical Analysis
TrendBullish
RSI57.1
Support¥1,761.50
Resistance¥1,906.00
MA 20¥1,840.05
MA 50¥1,789.63
MA 200¥1,540.08
MACDBearish
VolumeStable
Fear & Greed Index88.04
Valuation
Target Price¥1,944.17
Upside/Downside4.16%
GradeUndervalued
TypeBlend
Dividend Yield2.37%
Risk Assessment
Beta0.17
Volatility22.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.